# Zero Mention: Alto Didn't Flag Failing Drug in $120M Filing

- slug: zero-mention-alto-didnt-flag-failing-drug-in-120m-filing
- date: 2026-04-02
- category: Biotech & Life Sciences

ALTO-101 missed its primary endpoint in schizophrenia patients — but showed a signal in the sickest subgroup with no GI side effects. Alto is now looking for a buyer.

---